Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports

E. Bottini, F. I. Pareti, D. Mari, P. M. Mannucci, M. L. Muggiasca, M. Conti

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports'. Together they form a unique fingerprint.

Medicine & Life Sciences